HOME
CAREER NETWORK
NEWS
HOTBEDS
EVENT CENTER
CAREER FAIRS
COMPANY PROFILES
RESEARCH STORE
ABOUT US
NEWSLETTERS Free Newsletters Archive My eNewsletters NEWS News by Subject News by Disease News by Date PLoS Search News Post Your News JoVE CAREER NETWORK Job Seeker Login Most Recent Jobs Search Jobs Post Resume Career Fairs Career Resources For Employers COMMUNITY Login Become a Member Discussion Forums FAQ HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia BIOTECH WORK PORTAL Career Definitions Labor Market Reports Education & Training Regions DIVERSITY INVESTOR Market Summary News IPOs PROFILES Company Profiles START UPS Companies Events INTELLIGENCE Research Store INDUSTRY EVENTS Biotech Events Post an Event RESOURCES Real Estate Business Opportunities
<script language="javascript" src="http://at.ontargetjobs.com/addyn/3.0/701/1475036/0/681/ADTECH;loc=700;target=_blank;key=key1+key2+key3+key4;grp=[group]"></script><noscript><a href="http://at.ontargetjobs.com/adlink/3.0/701/1475036/0/681/ADTECH;loc=300;key=key1+key2+key3+key4;grp=[group]" target="_blank"><img src="http://at.ontargetjobs.com/adserv/3.0/701/1475036/0/681/ADTECH;loc=300;key=key1+key2+key3+key4;grp=[group]" border="0" width="160" height="240"></a></noscript>
Robin Beaumont, Chairman of Arana said: “We are delighted that Steffen has agreed to accept this role which involves his relocation to Australia for around 6 months. Steffen has excellent credentials with strong scientific, business management and global investor experience which equip him well for the position. In parallel, we are commissioning an international search for a permanent CEO.”
Dr Nock commented “Arana is in a very strong position in this turbulent economic environment by combining next generation platform technologies for antibody humanisation and engineering with a very deep product pipeline and a strong cash position. I am very excited to support Arana’s growth and international recognition as a major player in the therapeutic antibody space.”
About Arana Therapeutics: Arana Therapeutics (ASX: AAH) is a biopharmaceutical company focussed on developing next generation antibody based drugs that will improve the lives of patients with inflammatory diseases and cancer. Arana Therapeutics’ innovative engineering technologies provide the basis for developing its next generation antibody candidates. Arana Therapeutics has the financial strength and management expertise to develop its product pipeline. Arana has a significant track record of commercialising its technologies and has partnerships with GSK, CSL, KHK, Centocor (J&J) and Abbott Laboratories.
For further information: www.arana.com
Contact information: Company: Investor & Media Relations: Robin Beaumont Paul Dekkers Chairman Buchan Consulting Arana Therapeutics T: + 61 2 9237 2800 T: + 61 2 8061 9900 Mobile: 0418 218 722 E: rbeaumont@arana.com E: pdekkers@bcg.com.au